BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6712538)

  • 1. In vivo catabolism of biologically modified LDL.
    Nagelkerke JF; Havekes L; van Hinsbergh VW; van Berkel TJ
    Arteriosclerosis; 1984; 4(3):256-64. PubMed ID: 6712538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro catabolism of native and biologically modified LDL.
    Nagelkerke JF; Havekes L; van Hinsbergh VW; van Berkel TJ
    FEBS Lett; 1984 Jun; 171(1):149-53. PubMed ID: 6723973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue uptake of biologically modified low density lipoprotein in the rat.
    Henriksen T; Blomhoff R; Skretting G; Berg T; Eskild W
    Scand J Clin Lab Invest; 1987 May; 47(3):269-75. PubMed ID: 3589491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells.
    Van Berkel TJ; De Rijke YB; Kruijt JK
    J Biol Chem; 1991 Feb; 266(4):2282-9. PubMed ID: 1989982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clearance of acetyl low density lipoprotein by rat liver endothelial cells. Implications for hepatic cholesterol metabolism.
    Blomhoff R; Drevon CA; Eskild W; Helgerud P; Norum KR; Berg T
    J Biol Chem; 1984 Jul; 259(14):8898-903. PubMed ID: 6086616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells.
    Nagelkerke JF; Barto KP; van Berkel TJ
    J Biol Chem; 1983 Oct; 258(20):12221-7. PubMed ID: 6313644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid transport of fatty acids from rat liver endothelial to parenchymal cells after uptake of cholesteryl ester-labeled acetylated LDL.
    Nagelkerke JF; van Berkel TJ
    Biochim Biophys Acta; 1986 Feb; 875(3):593-8. PubMed ID: 3947660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of acetylated human low-density lipoprotein by parenchymal and non-parenchymal liver cells. Involvement of calmodulin?
    Van Berkel TJ; Nagelkerke JF; Harkes L; Kruijt JK
    Biochem J; 1982 Nov; 208(2):493-503. PubMed ID: 6130761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice.
    Van Berkel TJ; Van Velzen A; Kruijt JK; Suzuki H; Kodama T
    Biochem J; 1998 Apr; 331 ( Pt 1)(Pt 1):29-35. PubMed ID: 9512458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocytosis of acetylated low-density lipoprotein, endothelial cell-modified low-density lipoprotein, and formaldehyde-treated serum albumin by rat liver endothelial cells. Evidence of uptake via a common receptor.
    Eskild W; Henriksen T; Skretting G; Blomhoff R; Berg T
    Scand J Gastroenterol; 1987 Dec; 22(10):1263-9. PubMed ID: 3433016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of chemically modified low density lipoproteins in vivo is mediated by specific endothelial cells.
    Pitas RE; Boyles J; Mahley RW; Bissell DM
    J Cell Biol; 1985 Jan; 100(1):103-17. PubMed ID: 3965468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for reverse cholesterol transport in vivo from liver endothelial cells to parenchymal cells and bile by high-density lipoprotein.
    Bakkeren HF; Kuipers F; Vonk RJ; Van Berkel TJ
    Biochem J; 1990 Jun; 268(3):685-91. PubMed ID: 2363705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced macrophage degradation of biologically modified low density lipoprotein.
    Henriksen T; Mahoney EM; Steinberg D
    Arteriosclerosis; 1983; 3(2):149-59. PubMed ID: 6838433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative role of parenchymal and non-parenchymal liver cells in the uptake of [14C]sucrose-labelled low-density lipoprotein in vivo.
    Harkes L; Van Berkel JC
    Biochem J; 1984 Nov; 224(1):21-7. PubMed ID: 6508758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualization of the interaction of native and modified low density lipoproteins with isolated rat liver cells.
    Mommaas-Kienhuis AM; Nagelkerke JF; Vermeer BJ; Daems WT; van Berkel TJ
    Eur J Cell Biol; 1985 Jul; 38(1):42-50. PubMed ID: 4029176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver.
    Bijsterbosch MK; Van Berkel TJ
    Biochem J; 1990 Aug; 270(1):233-9. PubMed ID: 1697748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of the interaction of native and modified lipoproteins with parenchymal, endothelial and Kupffer cells from human liver.
    Kleinherenbrink-Stins MF; van de Boom JH; Schouten D; Roholl PJ; Niels van der Heyde M; Brouwer A; van Berkel TJ; Knook DL
    Hepatology; 1991 Jul; 14(1):79-90. PubMed ID: 1648542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake of LDL in parenchymal and non-parenchymal rabbit liver cells in vivo. LDL uptake is increased in endothelial cells in cholesterol-fed rabbits.
    Nenseter MS; Blomhoff R; Drevon CA; Kindberg GM; Norum KR; Berg T
    Biochem J; 1988 Sep; 254(2):443-8. PubMed ID: 2845951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified low density lipoproteins suppress production of a platelet-derived growth factor-like protein by cultured endothelial cells.
    Fox PL; DiCorleto PE
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4774-8. PubMed ID: 3460071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Processing of cholesteryl ester from low-density lipoproteins in the rat. Hepatic metabolism and biliary secretion after uptake by different hepatic cell types.
    Kuipers F; Nagelkerke JF; Bakkeren H; Havinga R; Van Berkel TJ; Vonk RJ
    Biochem J; 1989 Feb; 257(3):699-704. PubMed ID: 2930479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.